RIEFLIN WILLIAM JL has filed 8 insider transactions across 2 companies since March 2023.
Most recent transaction: a grant/award of 130000 shares of Lyell Immunopharma, Inc. ($LYEL) on May 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lyell Immunopharma, Inc. | $LYEL | RIEFLIN WILLIAM JL | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| June 14, 2024 | Lyell Immunopharma, Inc. | $LYEL | RIEFLIN WILLIAM JL | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | RAPT Therapeutics, Inc. | $RAPT | RIEFLIN WILLIAM JL | Not found | A | Stock Option (right to buy) | 36490 | $0.00 | 36,490.0000 | 0 | 9999.99% | 0.00% |
| March 28, 2024 | RAPT Therapeutics, Inc. | $RAPT | RIEFLIN WILLIAM JL | Not found | A | Stock Option (right to buy) | 11871 | $7.58 | 11,871.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Lyell Immunopharma, Inc. | $LYEL | RIEFLIN WILLIAM JL | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Lyell Immunopharma, Inc. | $LYEL | RIEFLIN WILLIAM JL | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | RAPT Therapeutics, Inc. | $RAPT | RIEFLIN WILLIAM JL | Director | A | Stock Option (right to buy) | 12940 | $0.00 | 12,940.0000 | 0 | 9999.99% | 0.00% |
| March 31, 2023 | RAPT Therapeutics, Inc. | $RAPT | RIEFLIN WILLIAM JL | Director | A | Stock Option (right to buy) | 6026 | $14.52 | 6,026.0000 | 0 | 9999.99% | 0.00% |